Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 7, 1998, Pages 555-560

  Kameyama, Tsutomu ^a   Ukai, Makoto ^a   Shinkai, Norihiro ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Memory; Mouse; Opioids; Spontaneous alternation performance; Tachykinins

Indexed keywords

BETA FUNALTREXAMINE; NALOXONE; NALTRINDOLE; NEUROKININ A; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE RECEPTOR; SCOPOLAMINE; SENKTIDE; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR;

AMNESIA; CONFERENCE PAPER; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SPATIAL MEMORY; SUBCUTANEOUS DRUG ADMINISTRATION; TASK PERFORMANCE; WORKING MEMORY;

ANIMALS; MALE; MICE; MUSCARINIC ANTAGONISTS; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NEUROKININ A; PEPTIDE FRAGMENTS; PSYCHOMOTOR PERFORMANCE; SCOPOLAMINE; SUBSTANCE P; TACHYKININS;

EID: 0031762668     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.7.485718     Document Type: Conference Paper

References (23)

1. Nakanishi, Y. Mammalian tachykinin receptors. Ann Rev Neurosci 1991, 14: 123-36.
2. Ukai, M., Shinkai, N., Ohashi, K., Kameyama, T. Substance P improves scopolamine-induced impairment of spontaneous alternation performance mediated via tachykinin NK-I receptors. Brain Res 1995, 673: 335-8.
3. Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K., Yankner, B.A. An in vivo model for the neurodegenerative effects of β-amyloid und protection by substance P. Proc Natl Acad Sci USA 1991, 88: 7247-51.
4. Hall, M.E., Stewart, J.M. The amnesic effects of β-amyloid fragments on passive avoidance responding in mice are blocked by substance P. Soc Neurosci Abst 1992, 18: 164.
5. Flood, J.F., Baker, M.L., Hernandez, E.N., Morley, J.E. Modulation of memory retention by neuropeptide K. Brain Res 1990, 520: 284-90.
6. Mauborgne, A., Lutz, O., Legrand, J.C., Hamon, M., Cesselin, F. Opposite effects of δ- and μ-opioid agonists on the in vitro release of substance P-like material from the rat spinal cord. J Neurochem 1987, 48: 529-37.
7. Larson, A.A. Desensitization to intrathecal substance P in mice: Possible involvement of opioids. Pain 1988, 32: 367-74.
8. Frederickson, R.C.A., Burgis, V., Harrell, C.E., Edwards, J.D. Dual actions of substance P on nociception: Possible role of endogenous opioids. Science 1978, 199: 1359-62.
9. Schlesinger, K., Lipsitz, D.U., Peck, P.L., Pelleymounter, M.A. Substance P reversal of electroconvulsive shock and cycloheximide-induced retrograde amnesia. Behav Neural Biol 1983, 39: 30-9.
10. Ukai, M., Shinkai, N., Kameyama, T. Effects of the tachykinin NK-3 receptor agonist senktide on memory process in mice. Japan J Psychopharmacol 1995, 15: 520.
11. Ukai, M., Kobayashi, T., Shinkai, N., Shan-Wu, X., Kameyama, T. Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in mice. Eur J Pharmacol 1995, 274: 89-93.
12. Haley, T.J., McCormick, W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 1957, 12: 12-5.
13. Sarter, M., Bodewitz, G., Stephens, D.N. Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology 1988, 94: 491-5.
14. Schlesinger, K., Lipsitz, D.U., Peck, P.L., Pelleymounter, M.A., Stewart, J.M., Chase, T.N. Substance P enhancement of passive and active avoidance conditioning in mice. Pharmacol Biochem Behav 1983, 19: 655-61.
15. Arenas, E., Alberch, J., Perez-Navarro, Solsona, C., Marsal, J. Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum. J Neurosci 1991, 11: 2332-8.
16. Crawley, J.N., Olschowka, J.A., Diz, D.I., Jacobowitz, D.M. Behavioral investigation of the coexistence of substance P, corticotropin releasing factor and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat. Peptides 1985, 6: 891-901.
17. 1]-γ-endorphin. Pharmacol Biochem Behav 1983, 19: 671-7.
18. Del Cerro, S., Borrell, J. β-Endorphin impairs forced extinction of an inhibitory avoidance response in rats. Life Sci 1987, 41: 579-84.
19. Doi, T., Jurna, I. Intrathecal substance P depresses the tail flick response-antagonism by naloxone. Naunyn-Schmied Arch Pharmacol 1981, 317: 135-9.
20. Itoh, J., Ukai, M., Kameyama, T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice. J Pharmacol Exp Ther 1994, 269: 15-21.
21. Sofuoglu, M., Portoghese, P.S., Takemori, A.E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 1991, 257: 676-80.
22. Ukai, M., Kameyama, T. Development study of therapeutic drugs for Alzheimer's disease by using biologically active peptides. Bull Res Inst Meijo Univ 1997, 2: 75-9.
23. 2, a novel dermorphin analog, impairs memory consolidation in mice. Eur J Pharmacol 1993, 239: 237-40.